Published on 23 May 2022 on Zacks via Yahoo Finance
Catalent, Inc. CTLT announced that it commenced a $175-million project to expand its flagship U.S. manufacturing facility for large-scale oral dose forms in Winchester, KY. The facility expansion, which is expected to be completed by January 2024, is expected to significantly add to the site’s manufacturing footprint.
Notably, the latest expansions follow a doubling of the site’s footprint in 2015 and a $40-million investment in 2019, which saw equipment installation for stick pack dosage manufacturing, integrated packaging lines, and expanded roller compaction and fluid bed capacity.
The expansion of the manufacturing facility is expected to significantly strengthen Catalent’s foothold in the global Softgel & Oral Technologies space.